Tags

Type your tag names separated by a space and hit enter

Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer.
Oncology (Williston Park). 1992 Jul; 6(7):23-6; discussion 26, 28.O

Abstract

A history of endometrial cancer has long been considered a contraindication to estrogen replacement therapy. Yet women with such a history, like other women when postmenopausal, often suffer vasomotor symptoms that could easily be relieved with estrogen. In fact there is no good evidence that estrogen significantly increases the risk of recurrence after treatment for endometrial cancer. Some studies now suggest that estrogen plus a progestin may actually decrease the risk of cancer recurrence in these patients. The benefits of estrogen in preventing osteoporosis and cardiovascular disease in postmenopausal women is substantial.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

1386238

Citation

Creasman, W T.. "Recommendations Regarding Estrogen Replacement Therapy After Treatment of Endometrial Cancer." Oncology (Williston Park, N.Y.), vol. 6, no. 7, 1992, pp. 23-6; discussion 26, 28.
Creasman WT. Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. Oncology (Williston Park, NY). 1992;6(7):23-6; discussion 26, 28.
Creasman, W. T. (1992). Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. Oncology (Williston Park, N.Y.), 6(7), 23-6; discussion 26, 28.
Creasman WT. Recommendations Regarding Estrogen Replacement Therapy After Treatment of Endometrial Cancer. Oncology (Williston Park, NY). 1992;6(7):23-6; discussion 26, 28. PubMed PMID: 1386238.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. A1 - Creasman,W T, PY - 1992/7/1/pubmed PY - 1992/7/1/medline PY - 1992/7/1/entrez SP - 23-6; discussion 26, 28 JF - Oncology (Williston Park, N.Y.) JO - Oncology (Williston Park, N.Y.) VL - 6 IS - 7 N2 - A history of endometrial cancer has long been considered a contraindication to estrogen replacement therapy. Yet women with such a history, like other women when postmenopausal, often suffer vasomotor symptoms that could easily be relieved with estrogen. In fact there is no good evidence that estrogen significantly increases the risk of recurrence after treatment for endometrial cancer. Some studies now suggest that estrogen plus a progestin may actually decrease the risk of cancer recurrence in these patients. The benefits of estrogen in preventing osteoporosis and cardiovascular disease in postmenopausal women is substantial. SN - 0890-9091 UR - https://www.unboundmedicine.com/medline/citation/1386238/Recommendations_regarding_estrogen_replacement_therapy_after_treatment_of_endometrial_cancer_ L2 - http://www.diseaseinfosearch.org/result/8312 DB - PRIME DP - Unbound Medicine ER -